H Lentzen
Overview
Explore the profile of H Lentzen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
41
Citations
245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sweeney E, Tonevitsky A, Palmer R, Niwa H, Pfueller U, Eck J, et al.
FEBS Lett
. 1998 Aug;
431(3):367-70.
PMID: 9714544
The quaternary structure of mistletoe lectin I (MLI), a type II ribosome inactivating protein, has been determined by X-ray crystallography. A definitive molecular replacement solution was determined for MLI using...
12.
Weber K, Mengs U, Schwarz T, Hajto T, Hostanska K, Allen T, et al.
Arzneimittelforschung
. 1998 Jun;
48(5):497-502.
PMID: 9638318
The immune response-modifying drug Lektinol is a mistletoe preparation which is standardized with respect to bioactive viscum album agglutinin, the most active component of mistletoe. The present study was designed...
13.
Shumakov V, Maisjuk I, Agapov I, Shamshiev A, Muromtceva I, Maluchenko N, et al.
Transplant Proc
. 1998 Jun;
30(4):971-3.
PMID: 9636392
No abstract available.
14.
Mockel B, Schwarz T, Zinke H, Eck J, Langer M, Lentzen H
Arzneimittelforschung
. 1997 Nov;
47(10):1145-51.
PMID: 9368710
The effects of mistletoe lectin I (ML I) on the human T-cell leukemia line MOLT-4, the monocytic line THP-1 and on human peripheral blood mononuclear cells (PBMC) were investigated with...
15.
Wenzel-Seifert K, Lentzen H, Aktories K, Seifert R
J Leukoc Biol
. 1997 Jun;
61(6):703-11.
PMID: 9201261
In human neutrophils, the chemotactic peptide, N-formyl-L-methionyl-L-leucyl-L-phenalalanine (fMLP), the Ca(2+)-ATPase inhibitor, thapsigargin, and the lectins, concanavalin A (Con A) and mistletoe lectin I (ML I), stimulate the entry of Ca2+...
16.
Wenzel-Seifert K, Lentzen H, Seifert R
Naunyn Schmiedebergs Arch Pharmacol
. 1997 Feb;
355(2):190-7.
PMID: 9050011
Mistletoe lectin I (ML I) from Viscum album inhibits cell growth and induces apoptosis (programmed cell death) in several cell types. Because increases in cytosolic Ca2+ concentration ([Ca2+]i) constitute a...
17.
Weber K, Mengs U, Schwarz T, Becker H, Lentzen H
Arzneimittelforschung
. 1996 Dec;
46(12):1174-8.
PMID: 9006795
Lektinol, is a special mistletoe preparation (SMP) with immunostimulatory activity, standardized with respect to bioactive mistletoe lectin, one of the most active components of mistletoe. In the present study, stimulation...
18.
Bokemeyer C, Fels L, Dunn T, Voigt W, Gaedeke J, Schmoll H, et al.
Br J Cancer
. 1996 Dec;
74(12):2036-41.
PMID: 8980410
Cisplatin is one of the most active cytotoxic agents in the treatment of testicular cancer, but its clinical use is associated with side-effects such as ototoxicity, neurotoxicity and nephrotoxicity. Long-term...
19.
20.
Wenzel-Seifert K, Krautwurst D, Lentzen H, Seifert R
J Leukoc Biol
. 1996 Sep;
60(3):345-55.
PMID: 8830791
The mannose-specific lectin, concanavalin A (ConA), activates Ca2+ entry in human neutrophils by an as yet poorly defined mechanism. The question of whether the sugar specificity of lectins influences signal...